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Abstract Incubation of human thrombocytes in the presence of 
[3H]palmitic acid leads to incorporation of this fatty acid into the 
a subunit of G, as described [Linder et aI., Proc. Natl. Acad. Sci. 
USA 90 (1993) 3675-3679; Degtyarev et aI., Biochemistry 32 
(1993) 8057-8061] but also into the catalyst of adenylyl cyclase 
which has not been recognized before. Treatment of labeled mem-
branes with hydroxylamine released the label from both compo-
nents. Label incorporated into the catalyst could be identified as 
[3H]palmitate. At the same time chemical deacylation caused 
partial loss of adenylyl cyclase activity. 
Key wordl': Adenylyl cyclase; Palmitoylation; Chemical 
deacylation 
1. Introduction 
Fatty acylation of proteins has been recognized for more 
than twenty years, While cotranslational myristoylation [1,2] of 
proteins is an irreversible process. posttranslational attachment 
of palmitic acid to a cysteine residue appears to be in a dynamic 
equilibrium of acylation/deacylation [3-5]. Myristoylation of 
G-protein a-subunits at a terminal glycine was considered to 
provide a means for anchoring proteins in the plasma mem-
brane [1.2] and was shown to increase the affinity of a o for j3y 
[6], Another lipid modification, isoprenylatlOn of a C-terminal 
cysteine residue occurs on the y-subunit of G-proteins and was 
found to be necessary for interaction of j3y-subunits with 
a-subunits and effectors [7]. In general addition of long alkyl 
chains to proteins may allow membrane attachment thus pro-
viding high local concentration of the protein. On the other 
hand it may aid interaction between subunits or other protein 
targets. 
In contrast to other a-subumts. as (and a q) lacks the terminal 
glycine and therefore is not myristoylated. but has been recently 
found to incorporate palmitic acid in labile thioester bond. 
While the question of whether this modification regulates mem-
brane association is still a matter of debate, there is evidence 
for impaired interaction with the catalyst when palmitoylation 
of as was Impeded by mutational replacement of Cys-3 by Ala 
[8]. 
Besides G-protein a-subunits. G-protein linked receptors. 
like rhodopsin, a- and j3-adrenoceptors, dopamine receptors 
etc. have been shown to be palmitoylated. However the conse-
quences of palmitoylation are disparate since mutation of rele-
vant cystcines sometimes leads to loss of stimulation of effector 
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Abbrel'zatlOns G,. stimulatory guanine nucleotide binding protein; 
a,. a-subumt of G,; GTPyS, guanosine-5'-O-(3-thlOtriphosphate). 
and prevention of desensitisation (/32-receptor [9]) but in other 
cases fails to perturb receptor-G-protein coupling (a2A-receptor 
[10]). Finally. depalmitoylation of membrane bound rhodopsin 
can even improve activation of its G-protein transducin [II]. 
The present study is aimed at a possible acylation of the 
effector part of the adenylyl cyclase system. We wanted to study 
deacylation by hydroxylaminolysis. because this occurs without 
damage of the protein and further more may be of advantage 
over the mutational approach eventually causing conforma-
tional changes. 
2. Materials and methods 
].1 Matenals 
Guanosme 5'-(3-thiotriphosphate). (GTPyS), creatme phosphate, 
creatine kmase, alkaline phosphatase. activated, were obtained from 
Boehnnger (Mannheim); Pansorbm (Staphylococcus aureus cells) was 
from Calbiochem; Trasylol was from Bayer; protein A and CSPD were 
from Serva; forskolin was a generous gift from Dr. H. Metzger, 
Hoechst (Frankfurt}. All other chemicals were of the highest punty 
commercially available. [a-32P1ATP (760 Ci/mmol) and ['HlcAMP 
(15-30 Ci/mmol) were obtained from Amersham Buchler (Braun-
schweig); eHlpalmitic acid (60 CI/mmol) was from BlOtrend (Kaln). 
] 2 Buffers 
Buffer A: 10 mM MOPS, I mM MgCI2, I mM EDTA, I mM ben-
zamidille. 0.02% NaN 3' 10,uM benzethonium chloride, 200,uM PMSF. 
2.8 ,ug/ml Trasylol, pH 7.0: Buffer B: 10 mM MOPS, 1% sucrose. I mM 
EDTA, I mM EGTA, 50,uM benzethonium chloride, 2.8 ,ug/ml Tra-
sylol. 40,uM PMSF. 0.1 mM DTE. 1 mM benzamidine pH 7.4; Buffer 
C. 10 mM MOPS. pH 7.4. I mM MgCI2, 1 mM EDTA, 1 mM Tween 
60.100 mM NaCI, Buffer D: 10 mM HEPES, pH 7.4,140 mM NaCI, 
25 mM KCl. 0 1 mM MgCI2, 10 mM NaHC03. 0.5 mM NaH2P04 , 
5 mM glucose. 
2 3. Preparation of platelet membranes 
Fresh platelets from healthy donors were obtained from DRK 
(Breltscheid) and membranes prepared therefrom as descnbed in [13] 
and stored at -70° C. 
] 4 1mlllunochemicals 
Antibody BBC-4 against the adenylyl cyclase catalyst was prepared 
and coupled to Pansorbm cells as described [14]. For immunodetection. 
antibody BBC-4 was coupled to alkalme phosphatase by a procedure 
suggested by the dlstnbutor. CSPD was used as substrate for the alka-
line phosphatase, the product of which was detected by chemilumllles-
cence. Antibody GSA 379 against a, was raised in rabbits according to 
Palm et al. [15]. 
2.5. Assays 
Adenylyl cyclase activity was measured m 30 mM MOPS. pH 7.4. 
10 mM creatine phosphate, 100,uM GTP. 20 ,ug/ml creatme kinase, 
4.5 mM theophylline, 2 mM MgCI2, 1 mM dithiothrelthol. 2 mg/ml 
bovine serum albumin, 0.1 mM [a-32P1ATP (1-2 x 10" cpm/test tube) 
for 20 min at 30°C. Protein estimation was performed accordlllg to 
Lowry et al. [16]. 
3. Results 
Fig. I. shows different functions of human platelet adenylyl 
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Fig. 1. Effect of hydroxylamille on human platelet adenylyl cyclase. 
Membranes (10 mg/ml) from platelets in buffer A were incubated with 
I M NH20H/HCI (hatched bars) or I M NaCI (open bars), adjusted 
to pH 7.0, for 30 min at 25°C. Followlllg washing twice with 20 volumes 
of buffer Band centnfugation at 30,000 x g for 10 min at 4°C. platelet 
membranes (70 pgltest) were assayed for adenylyl cyclase activity III the 
absence (Bas) and presence of 100 pM forskohn (Fo) or 10 pM PGE 1 
or 100 pM GTPyS plus 10 mM MgCI2 (GTPyS). The data are represen-
tative for at least seven independent expenments. 
cyclase after incubation of membranes with I M neutral hy-
droxylamine at 25°C. As is evident, basal, PGE- and forskolin-
stimulated activities were decreased by 70, 60 and 40%, respec-
tively. Surprisingly, stimulation by stable GTP-analogs was less 
affected than other functions. The reason for this is not entirely 
clear. However recent studies in this laboratory on chemical 
de acylation of as in various membranes point to an enhance-
ment of reconstitutive activity (Mollner, S., unpublished). 
Qualitatively similar results on adenylyl cyclase activity were 
obtained when rabbit myocardial membranes were treated with 
hydroxylamine (not shown). 
While the loss of forskolin-stimulated adenylyl cyclase activ-
ity on hydroxylamine treatment has already suggested impair-
ment of the catalytic function (Fig. I), experiments in Fig. 2 
were supporting this. Here, activated pure G s (Fig. 2A) was 
reconstituted with solubilized catalyst from thrombocytes. 
Again a significant decline in activity was apparent if mem-
branes had been subjected to hydroxyl aminolysis prior to solu-
bilisation. For comparison stimulation by forskolin (Fig. 2B) 
is shown which was reduced to the same degree as in mem-
branes. The effect on the soluble catalyst was not due to differ-
ential solubilisation as shown by Western blot analysis. The loss 
III catalyst activity on hydroxyl aminolysis was also observed 
with myocardial and erythrocyte membranes (not shown). 
Finally we were interested to learn whether the effects on 
catalytic activity could be correlated with loss of protein bound 
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acyl ate , preferably palmitate because of the observed sensitivity 
to hydroxylamine treatment. As a consequence we looked at 
incorporation of palmitic acid into the catalyst, as a hitherto 
unknown target of fatty acylation. For comparison we have 
monitored palmitoylation of as> already demonstrated in a va-
riety of other tissues. We treated fresh human thrombocytes 
with 5 .uM eH1paimitic acid, solubilized plasma membranes 
with SDS-containing RIPA-buffer and immunoprecipitated the 
catalyst and as a reference, the as moiety with the respective 
specific antibodies as described previously [14,17,18]. Analysis 
by SDS-PAGE confirms eH1palmitate-incorporation into as 
(Fig. 3A) but reveals [3H1acylation of the catalytic protein as 
well (Fig. 3B). The dotted lines indicate complete loss of label 
after treatment of membranes with hydroxylamine, suggesting 
that the fatty acid residue had been bound within a labile 
thioester bond. The upper pannels represent Western blots of 
gels run in parallel indicating that hydroxyl aminolysis did not 
cause loss of antigen in either case. Regarding the individual 
recoveries of both components after immunoprecipitation, the 
absolute amount of incorporated 3H into as was about three 
times that into the catalyst. This roughly matches the estimated 
abundance of these components in platelet membranes, ob-
tained by quantitative Western blot analysis (as) and approxi-
mation of amount of catalyst from enzymatic activity [181 and 
the turnover number of the pure catalyst [201.Fig. 4 compares 
removal of 3H from the 150 kDa catalyst and loss of forskolin-
stimulated activity as a function of hydroxylamine concentra-
tion. The results indicate that both events may be interdepend-
ent. Identification of the type of fatty acid incorporated into the 
catalytic protein revealed that almost 100% of the 3H label was 
released by NaOH and co migrated exclusively with palmitic 
acid when analysed by HPLC on an RP-18 column (Fig. 5). 
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Fig. 2. Influence of hydroxylamine-treatment on reconstItution of the 
catalyst With as' Membranes from platelets III buffer A (10 mg/ml) were 
treated with I M NH20H/HCI or I M NaCI for 30 min at 25°C, washed 
with buffer B (2 times with 20 volumes). Adenylyl cyclase from treated 
and control membranes was solubilized with cholate as described III [13] 
with the exception that 0.6% instead of 3% cholate was used. (A) 
Aliquots (10 pI) of solubilized membranes in buffer C were reconsti-
tuted III the adenylyl cyclase assay with variable amounts of pure G, 
(turkey erythrocytes, I ng/,ul) or were assayed in the presence of 100,uM 
forskohn (B). (Bas = basal activity, Fo = forskolin). The data are repre-
sentative for three expenments. 
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Fig. 3. Incorporation of [,H]palmltate mto a, (A) and into the catalytic 
unit (B) of adenylyl cyclase. Human platelets, resuspended to a final 
concentratlOn of 109 cells/ml m buffer D contaming 3.6 mg/ml fatty aCid 
free bovine serum albumin, 0.3 ,liM iloprost and I U/ml apyrase were 
mcubated in the presence of 5.uM [lH]palmitate (300 .uCi/ml) at 37°C 
for 120 mm. Platelets were washed twice with 6 ml each of buffer D and 
lysed as descnbed in [13]. Membranes (10 mglml) were resuspended in 
10 ml of buffer A plus 1 M NH20HIHCI or I M NaCI, left for 30 min 
at 25°C and washed with 0.5 ml of buffer B (3 times) by centrifugation 
at 30,000 x g for IS mm at 4°C (A) For immunoprecipltation of a" 
labeled membranes (1.2 mg) were solubilized with 500 .ul of RIPA 
buffer as described [14,18], followed by addition of 100 .ul affinity-
pUrIfied anti-a,-antibody (against C-terminal ammo aCids 379-397) 
After mcubation for ISO min at 4°C 70.ul of 30% Pansorbm in RIPA 
buffer were added and left for 75 mm at 4°C The washed Immunopre-
clpltate [14,18] was treated with lOO.u1 Laemmh-buffer [17] at 80°C 
centrifuged and applied to an II % SDS-polyacrylamide-gel. For esti-
mation of incorporated [lHJpalmitate, dried gels were cut mto 2 mm 
slices and mcubated with 150.ul water and 750.ul tissue solubilizer TS-I 
(Zinsser) for 180 mm at 50°C. After coolmg, 12 ml of scmtillant were 
added for countmg. Tracks a and b represent lH mcorporation Without 
(--) or \>,'Ith subsequent (---) hydroxylamme treatment. The msert 
shows a Western blot run m parallel for detectlOn of a, [18]. The a, 
migrates With an M, of 42 kDa: the 50 kDa band corresponds to the 
heavy cham of IgG which is also detected by [125I]Protein A. (B) For 
ImmunoprecipitatlOn of the catalytiC SUbUlllt, labeled membranes 
(I mg) were solubilized m 500 .ul RIPA buffer, illlxed With lOO.u1 30% 
BBC-4-Pansorbm conjugate and agitated for 180 mm at 22°C. Follow-
mg washmg [10.16J of the Immunopreclpltate, bound protein was re-
leased at 50°C With 100.ul of Laemmh-buffer [19] and subjected to 
polyacrylamide gel electrophoresIs (5-15%) as descnbed [14,1 8] For 
estimatIOn of mcorporated ['H]palmitate. gels were processed as m A. 
Track.s a and b represent lH mcorporatlOn followed by treatment With 
hydroxylamme (---) or not (--). The insert shows Westernblots run 
m parallel for detectlOn of catalyst [14.18] usmg an antibody BBC-4/ 
alkalme phosphatase conjugate and CSPD as chemilummescence sub-
strate The data are representatlve for two expenments with each sepa-
rately labeled cells. 
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4. Discussion 
This paper presents evidence that the hydroxylamine-in-
duced loss of forskolin stimulated and reconstitutive adenylyl 
cyclase activity on recombination with (1, may be explained by 
removal of one or more fatty acyl residues from the catalyst 
itself. Reversible palmitoylation of the latter could indeed be 
demonstrated following incubation of intact cells with 
eHlpalmitic acid. Fig. 3 shows that the 3H label which is precip-
itated by a monoclonal antibody recognizing a common motif 
of eukaryotic adenylyl cyclases (Mollner, S., unpublished) mi-
grates as a broad 150 kDa band on SDS gels, shape and Mr 
being consistent with those of adenylyl cyclase from human 
thrombocytes [18]. This is to our knowledge the first demon-
stration of a fatty-acid modified effector in a G-protein medi-
ated signal tansduction chain. In this respect it is also of interest 
that adenylyl cyclase from Bordetella pertussis was found to be 
amidically palmitoylated, a modification obviously necessary 
for effective entry into the host cell [21]. 
The role of acylation of eukaryotic adenylyl cyclases remains 
to be clarified. Forthcoming studies have also to show which 
subtypes of the enzyme are bearing this modification. The fact 
that adenylyl cyclases from other tissues, normally harboring 
several isoforms, are likewise deactivated by hydroxylamine 
treatment, points to a more common property. Of course a 
macromolecule like adenylyl cyclase catalyst spanning 12 times 
the bilayer does not need additional attachment to the mem-
brane. However, one or the other of the two large cytosolic 
domains, both comprising MrS of 40 kDa, may form an extra 
loop necessary to maintain a tertiary structure favourable for 
interaction with regulatory proteins and/or for optimal cata-
lytic efficiency. Further investigations including chemical and 
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Fig. 4. CorrelatlOn between NH,OH induced losses of catalyst-bound 
[lH]palmitate and cyclase actiVity. Platelets were labeled with 
l'H]palmltate as described m the legend to Fig. 3. Membranes were 
prepared and 1 mg (in 100 .ul) each, was treated With varIOUS concentra-
tions of NH,OH/HCI (e, A) or NaCI (0, .:,) as descnbed in legend for 
Fig. 3. 800.ug of protein each were used for measunng [lH]palmltate 
bound to the catalyst (A. 6) m gelshces 1-12 (see Fig. 3). A background 
level of 10-15 cpm/slice was subtracted. Adenylyl cyclase actlVlty (100 
,liM forskolin) was estlmated m parallel using 40 f.1g of membrane 
protein (e, '::0). 
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Fig. 5. I~entification of eH]fatty acid bound to the catalyst. Incorpora-
tIOn of [ H]fatty aCId was performed as elaborated m legend to Fig. 3. 
Following blotting onto the PVDF membrane, the relevant region was 
excIsed and treated with 0.75 ml I M NaOH for 30 min at 25°C 
Subsequent to addition of the same volume of I M HCI and 75 f.LI of 
2 M glycine HCI buffer pH 3.2, the mIxture was extracted with 1.5 ml 
n-hexane. The organic solvent was then concentrated and chroma to-
graphed on an RP C-18 HPLC column (Merck) developed with 80% 
(v/v) acetonitrile plus 17 mM orthophosphonc aCId (MA = mynstlc 
acid, PA = palmitic aCId). 
molecular biological methods to localize the acylated cyste-
ine(s) within the amino acid sequence of adenylyl cyclase are 
on the way. 
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